Diagnosis of an additional in situ melanoma does not influence survival for patients with a single invasive melanoma: A registry-based follow-up study

  • Danny R Youlden
  • , Kiarash Khosrotehrani
  • , Adèle C Green
  • , H Peter Soyer
  • , Michael G Kimlin
  • , Philippa H Youl
  • , Joanne F Aitken
  • , Peter D Baade

Research output: Contribution to journalArticlepeer-review

211 Downloads (Pure)

Abstract

Using a large (N= 25 493) population-based cohort from Queensland, Australia, we compared melanoma survival among cases with a single invasive melanoma only against those who also had a diagnosis of a single in situ melanoma. After adjustment for sex, age, body site, clinicopathological subtype, thickness and ulceration, it was found that there was no difference (P = 0.99) in 10-year melanoma-specific mortality following a diagnosis of an invasive lesion, whether or not an in situ melanoma was also present. We conclude that in situ melanomas do not alter the prognosis of an invasive melanoma.

Original languageEnglish
Pages (from-to)57-60
Number of pages4
JournalThe Australasian journal of dermatology
Volume57
Issue number1
DOIs
Publication statusPublished - Feb 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Cohort Studies
  • Female
  • Humans
  • Male
  • Melanoma
  • Middle Aged
  • Neoplasm Invasiveness
  • Neoplasms, Second Primary
  • Queensland
  • Registries
  • Skin Neoplasms
  • Survival Rate
  • Young Adult
  • Journal Article
  • Research Support, Non-U.S. Gov't

Fingerprint

Dive into the research topics of 'Diagnosis of an additional in situ melanoma does not influence survival for patients with a single invasive melanoma: A registry-based follow-up study'. Together they form a unique fingerprint.

Cite this